Municipal Employees' Retirement System of Michigan’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-23,050
Closed -$330K 932
2020
Q1
$330K Buy
23,050
+440
+2% +$9.29K 0.01% 875
2019
Q4
$616K Buy
22,610
+510
+2% +$14K 0.02% 770
2019
Q3
$633K Buy
22,100
+180
+0.8% +$5.25K 0.02% 696
2019
Q2
$609K Buy
21,920
+380
+2% +$10.7K 0.04% 729
2019
Q1
$715K Sell
21,540
-70
-0.3% -$2.13K 0.05% 606
2018
Q4
$628K Buy
+21,610
New +$777K 0.04% 754
2018
Q2
$737K Sell
19,710
-8,190
-29% -$277K 0.04% 762
2018
Q1
$824K Buy
27,900
+2,000
+8% +$67.7K 0.04% 787
2017
Q4
$890K Buy
25,900
+140
+0.5% +$4.72K 0.04% 724
2017
Q3
$932K Buy
25,760
+9,680
+60% +$276K 0.05% 646
2017
Q2
$416K Buy
16,080
+490
+3% +$10.4K 0.02% 1118
2017
Q1
$299K Buy
+15,590
New +$276K 0.01% 1321

Other funds holding MYGN

Municipal Employees' Retirement System of Michigan's MYGN Position: Q2 2020 in Review

Municipal Employees' Retirement System of Michigan sold out of Myriad Genetics (MYGN) in Q2 2020, closing a stake of 23,050 shares — an estimated $330K sold.

Municipal Employees' Retirement System of Michigan first reported a position in MYGN in Q1 2017 and held it in 12 quarters. The position peaked at $932K in Q3 2017. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2020.

  • Municipal Employees' Retirement System of Michigan reported no remaining Myriad Genetics position as of Q2 2020 after selling out during the quarter.
  • Municipal Employees' Retirement System of Michigan sold 23,050 Myriad Genetics shares in Q2 2020, an estimated $330K.
  • Municipal Employees' Retirement System of Michigan first reported a position in Myriad Genetics in Q1 2017 and held it in 12 quarters.
  • Municipal Employees' Retirement System of Michigan's Myriad Genetics position peaked at $932K in Q3 2017.
  • 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2020.

Based on Municipal Employees' Retirement System of Michigan's 13F filing for Q2 2020, filed 6 Jul 2020.